Treatment Details – 9.3 months

Survival: 9.3 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
Immunotherapy
   
Drugs: Adriamycin
Platinol
Country: Italy
   
City/State/Province: Milano
   
Hospital: Istituto Clinico Humanitas
   
Journal: Link
   
Date: 8/2001

Description:
Patients: This Phase II study involved 37 patients with malignant pleural mesothelioma who had not received chemotherapy or biological therapy before.

Treatment: The treatment consisted of the chemotherapy drugs cisplatin (platinol) and doxorubicin (adriamycin) with alpha-2b interferon.

Toxicity: Grade 4 toxicities included hematologic and renal.

Results: The median survival was 9.3 months.

Correspondence: Hector Soto Parra
Navigation